Literature DB >> 12739769

Evaluation of inhibitory activity of casein on proteases in rat intestine.

Seiji Ohtani1, Kyoko Shirasu, Ken-ichi Ogawara, Kazutaka Higaki, Toshikiro Kimura.   

Abstract

PURPOSE: To investigate the possible use of casein as an adjuvant for oral delivery of peptide drugs, the inhibitory activity of casein on proteases in rat small intestine was examined.
METHODS: Male Sprague-Dawley rats weighing 200-300 g were used as the animal model. The luminal contents of the small-intestinal tract and mucosal subcellular fractions of the small intestine were prepared: the enzymatic activities of trypsin, chymotrypsin, aminopeptidase-B, leucine aminopeptidase, dipeptidylaminopeptidase-IV, cathepsin B, and dipeptidylaminopeptidase-II were determined using a specific substrate for each protease; and the effect of casein on the protease activity was examined.
RESULTS: Casein strongly inhibited trypsin and chymotrypsin in the concentration-dependent manner. As to the proteases in the intestinal epithelial cells, casein inhibited an endopeptidase, cathepsin B, but not other exopeptidases. The inhibitory activity was independent of the type of casein. The kinetic analysis characterized the type of inhibition on trypsin and chymotrypsin to be competitive.
CONCLUSIONS: Casein was shown to have strong inhibitory activity on trypsin and chymotrypsin in the intestinal lumen. Taken into consideration that trypsin and chymotrypsin are endopeptidases, it is suggested that casein has strong inhibitory activity only on endopeptidases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739769     DOI: 10.1023/a:1023298816392

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  In vitro assessment of intestinal IGF-I stability.

Authors:  Pascale Anderle; Peter Langguth; Werner Rubas; Hans P Merkle
Journal:  J Pharm Sci       Date:  2002-01       Impact factor: 3.534

2.  The digestive function of the epithelium of the small intestine. II. Localization of disaccharide hydrolysis in the isolated brush border portion of intestinal epithelial cells.

Authors:  D MILLER; R K CRANE
Journal:  Biochim Biophys Acta       Date:  1961-09-16

3.  Fluorescence assay of x-prolyl dipeptidyl-aminopeptidase activity with a new fluorogenic substrate.

Authors:  T Kato; T Nagatsu; T Kimura; S Sakakibara
Journal:  Biochem Med       Date:  1978-06

4.  Casein phosphopeptides from casein micelles by successive digestion with pepsin and trypsin.

Authors:  T Ono; Y Takagi; I Kunishi
Journal:  Biosci Biotechnol Biochem       Date:  1998-01       Impact factor: 2.043

5.  Protease inhibitors and their relation to protease activity in human milk.

Authors:  T Lindberg; K Ohlsson; B Weström
Journal:  Pediatr Res       Date:  1982-06       Impact factor: 3.756

Review 6.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  A novel fluorometric ultramicro determination of serum leucine aminopeptidase using a coumarine derivative.

Authors:  K Saifuku; T Sekine; T Namihisa; T Takahashi; Y Kanaoka
Journal:  Clin Chim Acta       Date:  1978-03-01       Impact factor: 3.786

8.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

9.  Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin.

Authors:  S Kawabata; T Miura; T Morita; H Kato; K Fujikawa; S Iwanaga; K Takada; T Kimura; S Sakakibara
Journal:  Eur J Biochem       Date:  1988-02-15

10.  Degradation of IGF-I in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein.

Authors:  C J Xian; C A Shoubridge; L C Read
Journal:  J Endocrinol       Date:  1995-08       Impact factor: 4.286

View more
  1 in total

1.  Casein enhances stability of peptides in intestinal lumen: role of digested products of casein.

Authors:  Seiji Ohtani; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.